Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gyre Therapeutics (GYRE)  
$0.51 0.00 (0.00%) as of 4:30 Mon 10/30


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 31,350,000
Market Cap: 16.03(M)
Last Volume: 15,038 Avg Vol: 14,997
52 Week Range: $0.2246 - $0.648
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalyst Biosciences is a research and clinical development biopharmaceutical company. Co.'s complement portfolio consists of the development candidates CB 4332 and CB 2782-PEG. CB 4332 is a wholly owned, improved albumin-fused Complement Factor I (CFI) molecule intended for prophylactic subcutaneous or intravitreal administration in individuals with an imbalance in complement homeostasis or a CFI deficiency. CB 2782-PEG is a potential component 3 degrader product candidate in preclinical development for the treatment of dry age-related macular degeneration. Co. has several engineered protease programs in discovery or early non-clinical development.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 9,750
Total Buy Value $0 $0 $0 $4,584
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 3
Total Shares Sold 60,000 60,000 60,000 60,000
Total Sell Value $950,777 $950,777 $950,777 $950,777
Total People Sold 1 1 1 1
Total Sell Transactions 3 3 3 3
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 530
  Page 18 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bvf Inc/il Direct Beneficial Owner   –       –       •   2009-07-13 4 B $2.89 $6,361 D/D 2,200 2,690,809 2.37     -
   Bvf Inc/il Direct Beneficial Owner   –       –       •   2009-07-10 4 B $2.79 $5,578 D/D 2,000 2,688,609 2.37     -
   Bvf Inc/il Direct Beneficial Owner   –       –       •   2009-07-09 4 B $3.10 $66,646 D/D 21,500 2,686,609 2.45     -
   Lampert Mark N 10% Owner   –       –       •   2009-07-08 3 IO $0.00 $0 I/I 0 2,665,109     -
   Brown Julia R Director   –       •      –    2009-03-17 4 B $3.03 $22,725 D/D 7,500 7,500 2.39     -
   Debethizy J Donald President and CEO   •       •      –    2008-08-19 4 S $10.00 $17,000 D/D (1,700) 93,835     -
   Debethizy J Donald President and CEO   •       •      –    2008-08-19 4 OE $1.75 $2,975 D/D 1,700 95,535     -
   Dunbar Geoffrey C VP, Clin. Dev. & Reg. Affairs   •       –      –    2008-08-19 4 S $10.00 $12,810 D/D (1,281) 23,755     -
   Debethizy J Donald President and CEO   •       •      –    2008-08-18 4 S $10.01 $9,010 D/D (900) 93,835     -
   Debethizy J Donald President and CEO   •       •      –    2008-08-18 4 OE $1.75 $1,575 D/D 900 94,735     -
   Dunbar Geoffrey C VP, Clin. Dev. & Reg. Affairs   •       –      –    2008-08-18 4 S $10.00 $7,000 D/D (700) 25,036     -
   Musso Alan A VP, CFO & Treasurer   •       –      –    2008-08-15 4 S $10.00 $6,000 D/D (600) 2,799     -
   Musso Alan A VP, CFO & Treasurer   •       –      –    2008-08-15 4 OE $1.75 $1,050 D/D 600 3,399     -
   Debethizy J Donald President and CEO   •       •      –    2008-08-15 4 S $10.00 $1,000 D/D (100) 93,835     -
   Debethizy J Donald President and CEO   •       •      –    2008-08-15 4 OE $1.75 $175 D/D 100 93,935     -
   Dunbar Geoffrey C VP, Clin. Dev. & Reg. Affairs   •       –      –    2008-08-15 4 S $10.00 $1,000 D/D (100) 25,736     -
   Musso Alan A VP, CFO & Treasurer   •       –      –    2008-08-14 4 S $10.00 $16,230 D/D (1,623) 2,799     -
   Musso Alan A VP, CFO & Treasurer   •       –      –    2008-08-14 4 OE $1.75 $2,840 D/D 1,623 4,422     -
   Debethizy J Donald President and CEO   •       •      –    2008-08-14 4 S $10.00 $14,730 D/D (1,473) 93,835     -
   Debethizy J Donald President and CEO   •       •      –    2008-08-14 4 OE $1.75 $2,578 D/D 1,473 95,308     -
   Dunbar Geoffrey C VP, Clin. Dev. & Reg. Affairs   •       –      –    2008-08-14 4 S $10.00 $14,730 D/D (1,473) 25,836     -
   Musso Alan A VP, CFO & Treasurer   •       –      –    2008-08-13 4 S $10.00 $77,770 D/D (7,777) 2,799     -
   Musso Alan A VP, CFO & Treasurer   •       –      –    2008-08-13 4 OE $1.75 $13,610 D/D 7,777 5,076     -
   Debethizy J Donald President and CEO   •       •      –    2008-08-13 4 S $10.00 $23,240 D/D (2,324) 93,835     -
   Debethizy J Donald President and CEO   •       •      –    2008-08-13 4 OE $1.75 $4,067 D/D 2,324 96,159     -
  530 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 18 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us